Skip to main content

Find Clinical Trials

Home
Conditions
Refractory Solid Tumors in Children

Clinical trial condition

Refractory Solid Tumors in Children

Explore clinical trials studying Refractory Solid Tumors in Children. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Refractory Solid Tumors in Children trial results

Completed

Clinical Trial of Rapamycin and Irinotecan in Pediatric Patients With Refractory Solid Tumors

NCT01282697

Conditions: Refractory Solid Tumors in Children
Locations: Hôpital des Enfants - Groupe Hospitalier Pellegrin Bordeaux, France

Centre Oscar Lambret Lille, France

Institut Hémato-Oncologie Pédiatrique (IHOP) Lyon, France

CHU La Timone Marseille, France

View Trial Details

Completed

A Study of Vincristine, Escalating Doses of Irinotecan, Temozolomide and Bevacizumab (Vit-b) in Pediatric and Adolescent Patients With Recurrent or Refractory Solid Tumors of Non-hematopoietic Origin

NCT00993044

Conditions: Refractory Solid Tumors in Children
Locations: Childrens Hospital los Angeles Los Angeles, California, United States

View Trial Details